Aaron M Tejani

1.6k total citations
54 papers, 922 citations indexed

About

Aaron M Tejani is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Aaron M Tejani has authored 54 papers receiving a total of 922 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 12 papers in Pulmonary and Respiratory Medicine and 10 papers in Surgery. Recurrent topics in Aaron M Tejani's work include Blood Pressure and Hypertension Studies (7 papers), Hormonal Regulation and Hypertension (6 papers) and Gastroesophageal reflux and treatments (5 papers). Aaron M Tejani is often cited by papers focused on Blood Pressure and Hypertension Studies (7 papers), Hormonal Regulation and Hypertension (6 papers) and Gastroesophageal reflux and treatments (5 papers). Aaron M Tejani collaborates with scholars based in Canada, United States and United Kingdom. Aaron M Tejani's co-authors include Vijaya M Musini, Peter Loewen, Ken Bassett, James M Wright, Sarah Stabler, Michael Wasdell, Erica Wang, Douglas M Salzwedel, Lorri Puil and P Fortin and has published in prestigious journals such as Cochrane Database of Systematic Reviews, The American Journal of Cardiology and BMJ Open.

In The Last Decade

Aaron M Tejani

47 papers receiving 885 citations

Peers

Aaron M Tejani

CCM

EPIDE

EDM

SURGE

Ea Wha Kang South Korea

Ülver Derici Türkiye

Ouppatham Supasyndh Thailand

Rakesh Gupta India

Ursula C. Brewster United States

Yogita Rochlani United States

Leila Malekmakan Iran

David W. Mudge Australia

María José Fernández‐Reyes Spain

Isabel Hurtado Spain

Ea Wha Kang South Korea

Aaron M Tejani

184 ×0.7

CCM

130 ×0.7

EPIDE

137 ×1.0

EDM

116 ×1.1

SURGE

68 ×0.7

Citations per year, relative to Aaron M Tejani Aaron M Tejani (= 1×) peers Ea Wha Kang

Countries citing papers authored by Aaron M Tejani

Since Specialization

Citations

This map shows the geographic impact of Aaron M Tejani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron M Tejani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron M Tejani more than expected).

Fields of papers citing papers by Aaron M Tejani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron M Tejani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron M Tejani. The network helps show where Aaron M Tejani may publish in the future.

Co-authorship network of co-authors of Aaron M Tejani

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron M Tejani. A scholar is included among the top collaborators of Aaron M Tejani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron M Tejani. Aaron M Tejani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Musini, Vijaya M, et al.. (2025). Pharmacotherapy for hypertension in adults 60 years or older. Cochrane Database of Systematic Reviews. 2025(10). CD000028–CD000028.

Tejani, Aaron M & Thomas L. Perry. (2025). Reducing prescribing cascades. African Journal of Primary Health Care & Family Medicine. 17(1). e1–e4.

Tang, Linda, et al.. (2024). Understanding medication recycling practices in Canadian hospitals. International Journal of Pharmacy Practice. 32(4). 311–315. 1 indexed citations

Tejani, Aaron M, et al.. (2024). Standardized Orders for Salbutamol and Ipratropium: Do They Lead to Waste and Irrational Prescribing?. The Canadian Journal of Hospital Pharmacy. 77(3). e3561–e3561. 1 indexed citations

Wang, Ying, et al.. (2024). Prescribing Portraits to Optimize Prescribing of Proton Pump Inhibitors in Long-Term Care: PPI-T STOP Study. The Canadian Journal of Hospital Pharmacy. 77(1). e3461–e3461.

Tejani, Aaron M, et al.. (2023). Hiding in Plain Sight: Quantifying Salbutamol and Ipratropium Inhaler Wastage in Hospitals. The Canadian Journal of Hospital Pharmacy. 76(4). 314–316.

Tejani, Aaron M, et al.. (2023). Switching Topical Diclofenac from Higher to Lower Strength: Financial and Clinical Evaluation. The Canadian Journal of Hospital Pharmacy. 77(1). e3459–e3459.

Kirkham, Jamie J, et al.. (2020). Outcome reporting bias in Cochrane systematic reviews: a cross-sectional analysis. BMJ Open. 10(3). e032497–e032497. 6 indexed citations

Tejani, Aaron M, et al.. (2017). Going through the Motions: A Time-and- Motion Study of Workload Associated with Nonformulary Medication Orders. The Canadian Journal of Hospital Pharmacy. 70(2). 133–137. 1 indexed citations

10.

Tejani, Aaron M, et al.. (2017). 5α-Reductase Inhibitors for Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis. The Canadian Journal of Hospital Pharmacy. 70(2). 113–119. 12 indexed citations

11.

Tung, Anthony K. H., et al.. (2016). Identification of Patients Eligible for IV-to-PO Conversion: A Cost-Minimization Study. The Canadian Journal of Hospital Pharmacy. 69(4). 301–5. 7 indexed citations

12.

Lehman, Richard, et al.. (2015). Ten Commandments for patient-centred treatment. British Journal of General Practice. 65(639). 532–533. 6 indexed citations

13.

Tejani, Aaron M, et al.. (2015). Pharmacists’ Perceptions of the Influence of Interactions with the Pharmaceutical Industry on Clinical Decision-Making. The Canadian Journal of Hospital Pharmacy. 68(5). 378–85. 5 indexed citations

14.

Reid, Emma K., et al.. (2015). Managing the incidence of selective reporting bias: a survey of Cochrane review groups. Systematic Reviews. 4(1). 85–85. 16 indexed citations

15.

Lee, Jana C., et al.. (2012). Does Outcome Reporting Bias “Cause” Cancer? Risks Associated with Hidden Data on Angiotensin Receptor Blockers. The Canadian Journal of Hospital Pharmacy. 65(5). 387–93. 2 indexed citations

16.

Tejani, Aaron M, et al.. (2011). Impact of Academic Detailing on Proton Pump Inhibitor Prescribing Behaviour in a Community Hospital. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 144(2). 66–71. 3 indexed citations

17.

Tejani, Aaron M, et al.. (2010). Retrospective Analysis of Adherence to Thromboprophylaxis after Orthopedic Surgery in a Community Hospital. The Canadian Journal of Hospital Pharmacy. 63(2). 142–6. 1 indexed citations

18.

Eikelboom, John W., et al.. (2010). Explaining the RE-LY Trial. The Canadian Journal of Hospital Pharmacy. 63(4). 334–6. 1 indexed citations

19.

Tejani, Aaron M, et al.. (2009). Clinical Equivalency of Ciprofloxacin 750 mg Enterally and 400 mg Intravenously for Patients Receiving Enteral Feeding: Systematic Review. The Canadian Journal of Hospital Pharmacy. 62(2). 127–34. 7 indexed citations

20.

Arouni, Amy, et al.. (2000). Effect of estrogen on exercise electrocardiograms in healthy postmenopausal women. The American Journal of Cardiology. 86(4). 477–479. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact